about
28-mer Fragment Derived from Enterocin CRL35 Displays an Unexpected Bactericidal Effect on Listeria Cells.Cholesterol induces surface localization of polyphenols in model membranes thus enhancing vesicle stability against lysozyme, but reduces protection of distant double bonds from reactive-oxygen species.N-Acyl Chain in Ceramide and Sphingomyelin Determines Their Mixing Behavior, Phase State, and Surface Topography in Langmuir Films.Atypical surface behavior of ceramides with nonhydroxy and 2-hydroxy very long-chain (C28-C32) PUFAs.Microcin J25 membrane interaction: selectivity toward gel phase.Hexagonal phase with ordered acyl chains formed by a short chain asymmetric ceramide.Impairment of the class IIa bacteriocin receptor function and membrane structural changes are associated to enterocin CRL35 high resistance in Listeria monocytogenes.Interfacial stabilization of the antitumoral drug Paclitaxel in monolayers of GM1 and GD1a gangliosides.Selective Interaction of Colistin with Lipid Model Membranes.Microcin J25-Ga induces apoptosis in mammalian cells by inhibiting mitochondrial RNA-polymeraseCeramide N-acyl chain length: a determinant of bidimensional transitions, condensed domain morphology, and interfacial thicknessThe hydrophobic mismatch determines the miscibility of ceramides in lipid monolayersThe antimicrobial peptide microcin J25 stabilizes the gel phase of bacterial model membranesInteraction of cysteine and its derivatives with monolayers of dipalmitoylphosphatidylcholineStructure of gel phase DPPC determined by X-ray diffractionElastic behavior of model membranes with antimicrobial peptides depends on lipid specificity and d-enantiomersMembrane order and ionic strength modulation of the inhibition of the membrane-bound acetylcholinesterase by epigallocatechin‑3‑gallate
P50
Q40952498-2928F529-8885-4979-9D64-5F915D04B9BEQ46566165-E77A72EF-00B6-46D3-AD29-9683F1E681DCQ46876596-732B5B21-7EF4-4A9B-A9A5-CF4A2CB92A63Q46962316-0802E7B6-DBCC-44BE-BBDE-8A84EB30942EQ50280423-1E1581C7-A6BA-4DB2-9939-5C19F1AAEDDBQ50282835-98E1C5DD-3D8D-4949-B320-0E625E07220BQ51092448-8722103F-8F18-457E-8C34-96A007485E45Q53450367-3C65F44E-9322-4302-B109-05B5C15B7136Q53705816-DB369F45-1DC8-414C-8E5D-7A94CCBF693CQ61247378-3019819B-5603-4BF6-B90A-E301CCF67CD7Q83485355-07F24B25-0E29-4F0E-8752-4B86331EC43FQ84559072-A4302E23-549E-4BF0-BFBC-D8A46449CCBDQ87096431-9CBEEDA0-F1DD-4AE5-91FB-92C140AC97EFQ90719006-80930942-3E60-4222-9C15-0AD2B8217685Q90798857-AD25B699-7205-4AA0-9ECB-2B577F43E7C5Q91287691-FA40BFE4-1E47-4679-89B8-4C5BCBCC4CE1Q93334033-0FB30191-5D86-4286-BB05-93B8BA3EDEEC
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Fernando Dupuy
@en
Fernando Dupuy
@nl
type
label
Fernando Dupuy
@en
Fernando Dupuy
@nl
prefLabel
Fernando Dupuy
@en
Fernando Dupuy
@nl
P108
P31
P496
0000-0002-6799-8528